液体蛋氨酸增长势头良好 安迪苏营收净利双增长

Core Viewpoint - Andy Su has demonstrated strong revenue and profit growth in Q1 2025, driven by robust demand for its liquid methionine products and innovative service offerings [1][2]. Financial Performance - The company's revenue reached 4.299 billion yuan, a year-on-year increase of 22.98% - Net profit attributable to shareholders was 465 million yuan, up 67.85% year-on-year - Cash flow from operating activities amounted to 943 million yuan, reflecting a 47.11% increase year-on-year [1]. Business Operations - Andy Su is the only subsidiary of Sinochem Group focused on animal nutrition, with key products including methionine, specialty products, and vitamins [1]. - The company has achieved double-digit growth in liquid methionine over the past two years in the global market [1]. - Andy Su has built an integrated advantage in liquid methionine through a combination of process, equipment, and service innovations [2]. Market Dynamics - Strong downstream demand is expected to keep methionine prices stable in Q3, despite potential downward pressure from new domestic production capacity in the medium to long term [2]. - The company is currently the only supplier in China providing high-quality liquid feeding equipment for methionine [2]. Innovation and R&D - Innovation is a key competitive advantage for Andy Su, with ongoing research in advanced technologies, including synthetic biology for methionine production [3]. - The company is exploring new collaborative models within the group and seeking suitable acquisition targets to enhance its specialty product offerings [3]. Shareholder Engagement - Andy Su has implemented various market value management measures, including increasing the minimum dividend payout ratio to 40% and conducting regular communication with investors [3].